Search - tctmd.com

Displaying 181 - 200 of 261

Sort: Relevancy | Date

News Daily News

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

July 19, 2013

News Industry News

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

July 01, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

June 28, 2013

News Daily News

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Caitlin E. Cox

June 03, 2013

News Daily News

Meta-análisis confirma relación entre la dosis alta de FAINE y el riesgo vascular

Caitlin E. Cox

June 03, 2013

News Industry News

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

May 23, 2013

News Daily News

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

L.A. McKeown

May 17, 2013

News Daily News

Meta Análisis: La Denervación Renal es Efectiva con independencia del Tipo de Catéter

L.A. McKeown

May 17, 2013

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Daily News

Directrices de la ESC sobre el Uso Apropiado de la Denervación Renal basada en Catéter

April 26, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Caitlin E. Cox

April 19, 2013

News Daily News

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Caitlin E. Cox

March 09, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

February 25, 2013

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

January 16, 2013

Advertisement

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Meta-análisis confirma relación entre la dosis alta de FAINE y el riesgo vascular

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

Meta Análisis: La Denervación Renal es Efectiva con independencia del Tipo de Catéter

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

Directrices de la ESC sobre el Uso Apropiado de la Denervación Renal basada en Catéter

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

Unknowns Predominate in Variable Clopidogrel Response

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content